Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Jonathan M Meyer"'
Autor:
Michael J. Doane, Leona Bessonova, Haley S. Friedler, Kathleen M. Mortimer, Harry Cheng, Thomas Brecht, Amy K. O’Sullivan, Hannah Cummings, David McDonnell, Jonathan M. Meyer
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Many second-generation antipsychotics (SGAs) are associated with weight gain and cardiometabolic effects. Antipsychotic-associated weight gain is linked to treatment interruptions, potentially increasing risk of relapse and hospit
Externí odkaz:
https://doaj.org/article/2eccad05e5a7416594f176979e2a24dc
Autor:
Robert O. Cotes, Donna Rolin, Jonathan M. Meyer, Alexander S. Young, Amy N. Cohen, Tristan Gorrindo
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background Clozapine clinics can facilitate greater access to clozapine, but there is a paucity of data on their structure in the US. Methods A 23-item survey was administered to participants recruited from the SMI Adviser Clozapine Center o
Externí odkaz:
https://doaj.org/article/b9aeaff4faef4b31a5362b45233fccbb
Autor:
Jonathan M. Meyer, Adam Simmons, Ying Jiang, Christine Graham, Sergey Yagoda, David McDonnell
Publikováno v:
CNS Spectrums. :1-4
Objective A combination of olanzapine and the opioid receptor antagonist samidorphan (OLZ/SAM) has been approved in the United States for the treatment of adults with schizophrenia or adults with bipolar I disorder. In a phase 3 study in adults with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2858bce62c1a9cab33591b7ae2180eb2
https://doi.org/10.1017/s1092852922000967
https://doi.org/10.1017/s1092852922000967
Publikováno v:
Annals of General Psychiatry, Vol 16, Iss 1, Pp 1-9 (2017)
Abstract Background Severe and persistent mental illnesses, such as schizophrenia and bipolar disorder, are associated with increased risk of obesity compared to the general population. While the association of lurasidone and lower risk of weight gai
Externí odkaz:
https://doaj.org/article/63a5a11874134fc1b0beecc6f83ffbea
Autor:
Jonathan M. Meyer
Publikováno v:
Biomarkers in Neuropsychiatry, Vol 1, Iss , Pp - (2019)
Externí odkaz:
https://doaj.org/article/8f4b7c58300f42a79e7f4a4412c8f6ac
Autor:
Stephen M. Stahl, Jonathan M. Meyer
Publikováno v:
The Clinical Use of Antipsychotic Plasma Levels. :xiii-xx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b736fe257df19985bba7eaebe4cdad6e
https://doi.org/10.1017/9781009002103.002
https://doi.org/10.1017/9781009002103.002
Autor:
Amarpreet, Singh, Darci, Delgado, Maria I, Ventura, Eric, Schwartz, Jared, Williams, Jonathan M, Meyer
Publikováno v:
The journal of the American Academy of Psychiatry and the Law.
Referrals for competency restoration increased in the past decade, with the majority of incompetent to stand trial (IST) patients having schizophrenia; 25 percent of schizophrenia patients are treatment resistant. Clozapine is superior to other antip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ecfe0bbdf33b5d9dec061e9d34707645
https://pubmed.ncbi.nlm.nih.gov/35798392
https://pubmed.ncbi.nlm.nih.gov/35798392
Autor:
Jonathan M. Meyer, Cynthia L. Comella, Stanley N. Caroff, Robert A. Hauser, Leslie Lundt, Rose Mary Xavier, Caroline M. Tanner, Stewart A. Factor
Publikováno v:
CNS spectrums, vol 27, iss 2
Accurate diagnosis and appropriate treatment of tardive dyskinesia (TD) are imperative, as its symptoms can be highly disruptive to both patients and their caregivers. Misdiagnosis can lead to incorrect interventions with suboptimal or even deleterio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dcfdb3c06de39877dd1c48e5ffa7857
https://escholarship.org/uc/item/28q588v6
https://escholarship.org/uc/item/28q588v6
Publikováno v:
Case Reports in Psychiatry, Vol 2016 (2016)
Objective. Clozapine provides a 50%–60% response rate in refractory schizophrenia but has a narrow therapeutic index and is susceptible to pharmacokinetic interactions, particularly with strong inhibitors or inducers of cytochrome P450 (CYP) 1A2. C
Externí odkaz:
https://doaj.org/article/6cf0993c3e3e4130baa515616be55d3b
Autor:
Jonathan M. Meyer, Stephen M. Stahl
Clinicians recognize that monitoring psychotropic levels provides invaluable information to optimize therapy and track treatment adherence, but they lack formal training specifically focused on the use of plasma antipsychotic levels for these purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b59c11cb5b2ced5105976694299476ee
https://doi.org/10.1017/9781009002103
https://doi.org/10.1017/9781009002103